
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review
Mélissa Mialon, Stefanie Vandevijvere, Angela Carriedo‐Lutzenkirchen, et al.
BMJ Open (2020) Vol. 10, Iss. 7, pp. e034082-e034082
Open Access | Times Cited: 100
Mélissa Mialon, Stefanie Vandevijvere, Angela Carriedo‐Lutzenkirchen, et al.
BMJ Open (2020) Vol. 10, Iss. 7, pp. e034082-e034082
Open Access | Times Cited: 100
Showing 26-50 of 100 citing articles:
The corporate capture of the nutrition profession in the USA: the case of the Academy of Nutrition and Dietetics
Ángela Carriedo, Ilana Pinsky, Eric Crosbie, et al.
Public Health Nutrition (2022) Vol. 25, Iss. 12, pp. 3568-3582
Open Access | Times Cited: 20
Ángela Carriedo, Ilana Pinsky, Eric Crosbie, et al.
Public Health Nutrition (2022) Vol. 25, Iss. 12, pp. 3568-3582
Open Access | Times Cited: 20
Conflict of Interests in the Scientific Production on Vitamin D and COVID-19: A Scoping Review
Carolina Saggioro Meissonier Passini, Maria Birman Cavalcanti, Simone Augusta Ribas, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 19
Carolina Saggioro Meissonier Passini, Maria Birman Cavalcanti, Simone Augusta Ribas, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 19
Poisoning Regulation, Research, Health, and the Environment: The Glyphosate-Based Herbicides Case in Canada
Marie-Hélène Bacon, Louise Vandelac, Marc‐André Gagnon, et al.
Toxics (2023) Vol. 11, Iss. 2, pp. 121-121
Open Access | Times Cited: 12
Marie-Hélène Bacon, Louise Vandelac, Marc‐André Gagnon, et al.
Toxics (2023) Vol. 11, Iss. 2, pp. 121-121
Open Access | Times Cited: 12
Mapping commercial practices of the pesticide industry to shape science and policymaking: a scoping review
Lisa Schölin, Mark Petticrew, Jeff Collin, et al.
Health Promotion International (2025) Vol. 40, Iss. 1
Open Access
Lisa Schölin, Mark Petticrew, Jeff Collin, et al.
Health Promotion International (2025) Vol. 40, Iss. 1
Open Access
Quick buys for prevention and control of noncommunicable diseases
Gauden Galea, Allison Ekberg, Angela Ciobanu, et al.
The Lancet Regional Health - Europe (2025), pp. 101281-101281
Open Access
Gauden Galea, Allison Ekberg, Angela Ciobanu, et al.
The Lancet Regional Health - Europe (2025), pp. 101281-101281
Open Access
The attributes of public health leadership
Martin McKee
European Journal of Public Health (2025) Vol. 35, Iss. Supplement_2, pp. ii1-ii4
Open Access
Martin McKee
European Journal of Public Health (2025) Vol. 35, Iss. Supplement_2, pp. ii1-ii4
Open Access
Characterizing COVID-19 Transmission: Incubation Period, Reproduction Rate, and Multiple-Generation Spreading
Lin Zhang, Jiahua Zhu, Xuyuan Wang, et al.
Frontiers in Physics (2021) Vol. 8
Open Access | Times Cited: 26
Lin Zhang, Jiahua Zhu, Xuyuan Wang, et al.
Frontiers in Physics (2021) Vol. 8
Open Access | Times Cited: 26
Obesity, public health ethics and the nanny state
M. William Steele, Mélissa Mialon, Sarah Browne, et al.
Ethics Medicine and Public Health (2021) Vol. 19, pp. 100724-100724
Open Access | Times Cited: 24
M. William Steele, Mélissa Mialon, Sarah Browne, et al.
Ethics Medicine and Public Health (2021) Vol. 19, pp. 100724-100724
Open Access | Times Cited: 24
Tracing the connections between international business and communicable diseases
Ivan Montiel, Junghoon Park, Bryan W. Husted, et al.
Journal of International Business Studies (2022) Vol. 53, Iss. 8, pp. 1785-1804
Open Access | Times Cited: 17
Ivan Montiel, Junghoon Park, Bryan W. Husted, et al.
Journal of International Business Studies (2022) Vol. 53, Iss. 8, pp. 1785-1804
Open Access | Times Cited: 17
Taking on the Corporate Determinants of Ill-health and Health Inequity: A Scoping Review of Actions to Address Excessive Corporate Power to Protect and Promote the Public’s Health
Benjamin Wood, Jennifer Lacy‐Nichols, Gary Sacks
International Journal of Health Policy and Management (2023) Vol. 12, pp. 7304-7304
Open Access | Times Cited: 10
Benjamin Wood, Jennifer Lacy‐Nichols, Gary Sacks
International Journal of Health Policy and Management (2023) Vol. 12, pp. 7304-7304
Open Access | Times Cited: 10
Biology of COVID-19 and related viruses: Epidemiology, signs, symptoms, diagnosis, and treatment
Alan D. Kaye, Elyse M. Cornett, Kimberley C. Brondeel, et al.
Best Practice & Research Clinical Anaesthesiology (2020) Vol. 35, Iss. 3, pp. 269-292
Open Access | Times Cited: 24
Alan D. Kaye, Elyse M. Cornett, Kimberley C. Brondeel, et al.
Best Practice & Research Clinical Anaesthesiology (2020) Vol. 35, Iss. 3, pp. 269-292
Open Access | Times Cited: 24
The Commercial Determinants of Three Contemporary National Crises: How Corporate Practices Intersect With the COVID‐19 Pandemic, Economic Downturn, and Racial Inequity
Nason Maani, May C I van Schalkwyk, Mark Petticrew, et al.
Milbank Quarterly (2021) Vol. 99, Iss. 2, pp. 503-518
Open Access | Times Cited: 21
Nason Maani, May C I van Schalkwyk, Mark Petticrew, et al.
Milbank Quarterly (2021) Vol. 99, Iss. 2, pp. 503-518
Open Access | Times Cited: 21
Where next for the WHO Framework Convention on Tobacco Control?
Stella Aguinaga Bialous, Vera Luiza da Costa e Silva
Tobacco Control (2022) Vol. 31, Iss. 2, pp. 183-186
Open Access | Times Cited: 14
Stella Aguinaga Bialous, Vera Luiza da Costa e Silva
Tobacco Control (2022) Vol. 31, Iss. 2, pp. 183-186
Open Access | Times Cited: 14
Understanding the corporate political activity of the ultra - processed food industry in East Asia: a Philippines case study
Oliver Huse, Erica Reeve, Paul Zambrano, et al.
Globalization and Health (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Oliver Huse, Erica Reeve, Paul Zambrano, et al.
Globalization and Health (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 8
The Commercial Determinants of Health and Evidence Synthesis (CODES): methodological guidance for systematic reviews and other evidence syntheses
Mark Petticrew, R. E. Glover, Jimmy Volmink, et al.
Systematic Reviews (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Mark Petticrew, R. E. Glover, Jimmy Volmink, et al.
Systematic Reviews (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Australia in 2030: what is our path to health for all?
Sharon Friel, Fran Baum, Sharon Goldfeld, et al.
The Medical Journal of Australia (2021) Vol. 214, Iss. S8
Open Access | Times Cited: 19
Sharon Friel, Fran Baum, Sharon Goldfeld, et al.
The Medical Journal of Australia (2021) Vol. 214, Iss. S8
Open Access | Times Cited: 19
International internships and skill development: A systematic review
Giorgio Di Pietro
Review of Education (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 13
Giorgio Di Pietro
Review of Education (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 13
Exploring Public Health Research for Corporate Health Policy: Insights for Business and Society Scholars
Lilia Raquel Rojas-Cruz, Irene Henriques, Bryan W. Husted
Business & Society (2024)
Closed Access | Times Cited: 2
Lilia Raquel Rojas-Cruz, Irene Henriques, Bryan W. Husted
Business & Society (2024)
Closed Access | Times Cited: 2
Analysis of public records of lobbying practices of the ultra-processed sugary food and drink industries in Chile: a qualitative study
Yanela Aravena‐Rivas, Anja Heilmann, Richard G. Watt, et al.
The Lancet Regional Health - Americas (2024) Vol. 35, pp. 100794-100794
Open Access | Times Cited: 2
Yanela Aravena‐Rivas, Anja Heilmann, Richard G. Watt, et al.
The Lancet Regional Health - Americas (2024) Vol. 35, pp. 100794-100794
Open Access | Times Cited: 2
Dynamics of combatting market-driven epidemics: Insights from U.S. reduction of cigarette, sugar, and prescription opioid consumption
Eszter Rimányi, Jonathan D. Quick, Gavin Yamey, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 7, pp. e0003479-e0003479
Open Access | Times Cited: 2
Eszter Rimányi, Jonathan D. Quick, Gavin Yamey, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 7, pp. e0003479-e0003479
Open Access | Times Cited: 2
Validity, reliability, and calibration of the physical activity unit 7 item screener (PAU-7S) at population scale
Helmut Schröder, Isaac Subirana, Julia Wärnberǵ, et al.
International Journal of Behavioral Nutrition and Physical Activity (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Helmut Schröder, Isaac Subirana, Julia Wärnberǵ, et al.
International Journal of Behavioral Nutrition and Physical Activity (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Enhancing our understanding of the commercial determinants of health: Theories, methods, and insights from political science
Eduardo J. Gómez
Social Science & Medicine (2022) Vol. 301, pp. 114931-114931
Closed Access | Times Cited: 12
Eduardo J. Gómez
Social Science & Medicine (2022) Vol. 301, pp. 114931-114931
Closed Access | Times Cited: 12
Typology of how ‘harmful commodity industries’ interact with local governments in England: a critical interpretive synthesis
Sarah McKevitt, Martin White, Mark Petticrew, et al.
BMJ Global Health (2023) Vol. 8, Iss. 1, pp. e010216-e010216
Open Access | Times Cited: 6
Sarah McKevitt, Martin White, Mark Petticrew, et al.
BMJ Global Health (2023) Vol. 8, Iss. 1, pp. e010216-e010216
Open Access | Times Cited: 6
Framing Commercial Determinants of Health: An Assessment of Potential for Guiding More Effective Responses to the Public Health Crises of the 21st Century
Nicholas Freudenberg
Milbank Quarterly (2023) Vol. 101, Iss. S1, pp. 83-98
Open Access | Times Cited: 6
Nicholas Freudenberg
Milbank Quarterly (2023) Vol. 101, Iss. S1, pp. 83-98
Open Access | Times Cited: 6
What did the scientific literature learn from internal company documents in the pharmaceutical industry? A scoping review
Marc‐André Gagnon, Blue Miaoran Dong
Cochrane Evidence Synthesis and Methods (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 6
Marc‐André Gagnon, Blue Miaoran Dong
Cochrane Evidence Synthesis and Methods (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 6